TURKU, FINLAND: Faron Pharmaceuticals Oy, the clinical stage biopharmaceutical company, has been selected to receive a €2.5 million grant from the European Innovation Council (EIC) Accelerator pilot scheme to progress the MATINS Study and related business activities. The EIC Accelerator pilot scheme supports top-class innovators, entrepreneurs, small companies and scientists with funding opportunities to support…